Results Healthcare Appoints Anthony Harrington as Manager
News Aug 08, 2013
A graduate of National University Cork, Ireland, where he achieved a First in Business Economics and a BSc, Finance, First Class, Anthony most recently worked as a corporate finance consultant for Survitec Group and Enteq Upstream PLC. Prior to this he was Associate Director in the corporate finance department of Investec PLC. During his time at Investec, Anthony was involved in a number of significant transactions, including the sale of Arena Leisure PLC, the IPO of and subsequent fundraising for Enteq Upstream PLC, as well as acquisitions for Enteq and a fundraising for Digital Barriers PLC.
Before joining Investec, Anthony spent four years in the healthcare team at Rothschild. Here he worked on a wide variety of transactions, such as the sale of a minority stake in an Irish probiotics company, the private placement of a minority stake in an Indian pharmaceutical manufacturer, the acquisition by BTG PLC of Protherics PLC, the disposal of a non-core product portfolio by Shire PLC to Almirall and the sale of Huntleigh PLC to Getinge.
Anthony has a further two years healthcare experience, having worked as an Analyst with the healthcare team at Bear Stearns.
"We are pleased to welcome Anthony to our expanding healthcare team," commented Results Healthcare Managing Director, Kevin Bottomley. "His extensive healthcare experience and broad industry knowledge will further add to the skill set that we have within the Results Healthcare organisation."
Children With Congenital Zika Virus Infection Face Serious Challenges as They AgeNews
The report from the CDC is the first to describe the health and developmental effects of congenital Zika virus infection in children with microcephaly through 2 years of age.READ MORE
Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories ForwardNews
First nanotechnological approach enables the design and replication of complex single-stranded DNA and RNA origami with potential for drug delivery and nanofabrication.READ MORE